Per Wold-Olsen

GN Hearing A/S develops and sells hearings aids and tools for measuring loss of hearing capability. It provides solutions for all types of ear-related diagnostics and distributes computerized audiology and hearing-instrument fitting equipment. The company was founded in 1957 and is headquartered in Ballerup, Denmark.

Part of GN Store Nord A/S, GN Netcom A/S's sister brand, BlueParrott, specializes in noise cancelling headsets for professional drivers. The private company is based in Ballerup, Denmark. Jabra, another brand under GN Netcom, develops, manufactures, and markets a wide range of wireless and corded headsets for mobile users, call centers, and offices. The Danish company provides tools to help businesses of all sizes become fast, flexible, and efficient, and increase customer loyalty. Jabra's compatible headsets and speakerphones are designed to deliver a seamless, intuitive experience for various platforms and solutions, including Amazon Connect and Amazon Chime. René Svendsen-Tune has been the CEO of the company since 2015.

GN Audio A/S develops, manufactures, and markets hands-free communication products to the call center, office, and personal computer applications markets. Its products include corded and wireless headsets, amplifiers for headsets, headset telephones, and adapters for computer and internet telephony. The company was founded on August 30, 1967 and is headquartered in Ballerup, Denmark.

GN Hearing A/S develops and sells hearings aids and tools for measuring loss of hearing capability. It provides solutions for all types of ear-related diagnostics and distributes computerized audiology and hearing-instrument fitting equipment. The company was founded in 1957 and is headquartered in Ballerup, Denmark.

GN Hearing A/S develops and sells hearings aids and tools for measuring loss of hearing capability. It provides solutions for all types of ear-related diagnostics and distributes computerized audiology and hearing-instrument fitting equipment. The company was founded in 1957 and is headquartered in Ballerup, Denmark.

Part of GN Store Nord A/S, GN Netcom A/S's sister brand, BlueParrott, specializes in noise cancelling headsets for professional drivers. The private company is based in Ballerup, Denmark. Jabra, another brand under GN Netcom, develops, manufactures, and markets a wide range of wireless and corded headsets for mobile users, call centers, and offices. The Danish company provides tools to help businesses of all sizes become fast, flexible, and efficient, and increase customer loyalty. Jabra's compatible headsets and speakerphones are designed to deliver a seamless, intuitive experience for various platforms and solutions, including Amazon Connect and Amazon Chime. René Svendsen-Tune has been the CEO of the company since 2015.

Forepont Capital LLC (Forepont Capital Partners) is a venture capital firm founded in 2014 by Eric M. Attias. The firm is headquartered in New York with an additional office in Paris, France.

GN Hearing A/S develops and sells hearings aids and tools for measuring loss of hearing capability. It provides solutions for all types of ear-related diagnostics and distributes computerized audiology and hearing-instrument fitting equipment. The company was founded in 1957 and is headquartered in Ballerup, Denmark.

GN Audio A/S develops, manufactures, and markets hands-free communication products to the call center, office, and personal computer applications markets. Its products include corded and wireless headsets, amplifiers for headsets, headset telephones, and adapters for computer and internet telephony. The company was founded on August 30, 1967 and is headquartered in Ballerup, Denmark.

GN Audio A/S develops, manufactures, and markets hands-free communication products to the call center, office, and personal computer applications markets. Its products include corded and wireless headsets, amplifiers for headsets, headset telephones, and adapters for computer and internet telephony. The company was founded on August 30, 1967 and is headquartered in Ballerup, Denmark.

Part of GN Store Nord A/S, GN Netcom A/S's sister brand, BlueParrott, specializes in noise cancelling headsets for professional drivers. The private company is based in Ballerup, Denmark. Jabra, another brand under GN Netcom, develops, manufactures, and markets a wide range of wireless and corded headsets for mobile users, call centers, and offices. The Danish company provides tools to help businesses of all sizes become fast, flexible, and efficient, and increase customer loyalty. Jabra's compatible headsets and speakerphones are designed to deliver a seamless, intuitive experience for various platforms and solutions, including Amazon Connect and Amazon Chime. René Svendsen-Tune has been the CEO of the company since 2015.

GN Audio A/S develops, manufactures, and markets hands-free communication products to the call center, office, and personal computer applications markets. Its products include corded and wireless headsets, amplifiers for headsets, headset telephones, and adapters for computer and internet telephony. The company was founded on August 30, 1967 and is headquartered in Ballerup, Denmark.

GN Hearing A/S develops and sells hearings aids and tools for measuring loss of hearing capability. It provides solutions for all types of ear-related diagnostics and distributes computerized audiology and hearing-instrument fitting equipment. The company was founded in 1957 and is headquartered in Ballerup, Denmark.

GN Hearing A/S develops and sells hearings aids and tools for measuring loss of hearing capability. It provides solutions for all types of ear-related diagnostics and distributes computerized audiology and hearing-instrument fitting equipment. The company was founded in 1957 and is headquartered in Ballerup, Denmark.

Part of GN Store Nord A/S, GN Netcom A/S's sister brand, BlueParrott, specializes in noise cancelling headsets for professional drivers. The private company is based in Ballerup, Denmark. Jabra, another brand under GN Netcom, develops, manufactures, and markets a wide range of wireless and corded headsets for mobile users, call centers, and offices. The Danish company provides tools to help businesses of all sizes become fast, flexible, and efficient, and increase customer loyalty. Jabra's compatible headsets and speakerphones are designed to deliver a seamless, intuitive experience for various platforms and solutions, including Amazon Connect and Amazon Chime. René Svendsen-Tune has been the CEO of the company since 2015.

GN Audio A/S develops, manufactures, and markets hands-free communication products to the call center, office, and personal computer applications markets. Its products include corded and wireless headsets, amplifiers for headsets, headset telephones, and adapters for computer and internet telephony. The company was founded on August 30, 1967 and is headquartered in Ballerup, Denmark.

Forepont Capital LLC (Forepont Capital Partners) is a venture capital firm founded in 2014 by Eric M. Attias. The firm is headquartered in New York with an additional office in Paris, France.

Forepont Capital LLC (Forepont Capital Partners) is a venture capital firm founded in 2014 by Eric M. Attias. The firm is headquartered in New York with an additional office in Paris, France.

GN Hearing A/S develops and sells hearings aids and tools for measuring loss of hearing capability. It provides solutions for all types of ear-related diagnostics and distributes computerized audiology and hearing-instrument fitting equipment. The company was founded in 1957 and is headquartered in Ballerup, Denmark.

Part of GN Store Nord A/S, GN Netcom A/S's sister brand, BlueParrott, specializes in noise cancelling headsets for professional drivers. The private company is based in Ballerup, Denmark. Jabra, another brand under GN Netcom, develops, manufactures, and markets a wide range of wireless and corded headsets for mobile users, call centers, and offices. The Danish company provides tools to help businesses of all sizes become fast, flexible, and efficient, and increase customer loyalty. Jabra's compatible headsets and speakerphones are designed to deliver a seamless, intuitive experience for various platforms and solutions, including Amazon Connect and Amazon Chime. René Svendsen-Tune has been the CEO of the company since 2015.

GN Hearing A/S develops and sells hearings aids and tools for measuring loss of hearing capability. It provides solutions for all types of ear-related diagnostics and distributes computerized audiology and hearing-instrument fitting equipment. The company was founded in 1957 and is headquartered in Ballerup, Denmark.

Part of GN Store Nord A/S, GN Netcom A/S's sister brand, BlueParrott, specializes in noise cancelling headsets for professional drivers. The private company is based in Ballerup, Denmark. Jabra, another brand under GN Netcom, develops, manufactures, and markets a wide range of wireless and corded headsets for mobile users, call centers, and offices. The Danish company provides tools to help businesses of all sizes become fast, flexible, and efficient, and increase customer loyalty. Jabra's compatible headsets and speakerphones are designed to deliver a seamless, intuitive experience for various platforms and solutions, including Amazon Connect and Amazon Chime. René Svendsen-Tune has been the CEO of the company since 2015.

MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland.

MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland.

MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland.

Forepont Capital LLC (Forepont Capital Partners) is a venture capital firm founded in 2014 by Eric M. Attias. The firm is headquartered in New York with an additional office in Paris, France.

MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland.

MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland.

Forepont Capital LLC (Forepont Capital Partners) is a venture capital firm founded in 2014 by Eric M. Attias. The firm is headquartered in New York with an additional office in Paris, France.

Forepont Capital LLC (Forepont Capital Partners) is a venture capital firm founded in 2014 by Eric M. Attias. The firm is headquartered in New York with an additional office in Paris, France.

MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland.

MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland.

MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland.

Forepont Capital LLC (Forepont Capital Partners) is a venture capital firm founded in 2014 by Eric M. Attias. The firm is headquartered in New York with an additional office in Paris, France.

MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland.

MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland.

Forepont Capital LLC (Forepont Capital Partners) is a venture capital firm founded in 2014 by Eric M. Attias. The firm is headquartered in New York with an additional office in Paris, France.

MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland.

Forepont Capital LLC (Forepont Capital Partners) is a venture capital firm founded in 2014 by Eric M. Attias. The firm is headquartered in New York with an additional office in Paris, France.

MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland.

MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland.

GN Hearing A/S develops and sells hearings aids and tools for measuring loss of hearing capability. It provides solutions for all types of ear-related diagnostics and distributes computerized audiology and hearing-instrument fitting equipment. The company was founded in 1957 and is headquartered in Ballerup, Denmark.

GN Hearing A/S develops and sells hearings aids and tools for measuring loss of hearing capability. It provides solutions for all types of ear-related diagnostics and distributes computerized audiology and hearing-instrument fitting equipment. The company was founded in 1957 and is headquartered in Ballerup, Denmark.

GN Hearing A/S develops and sells hearings aids and tools for measuring loss of hearing capability. It provides solutions for all types of ear-related diagnostics and distributes computerized audiology and hearing-instrument fitting equipment. The company was founded in 1957 and is headquartered in Ballerup, Denmark.

GN Hearing A/S develops and sells hearings aids and tools for measuring loss of hearing capability. It provides solutions for all types of ear-related diagnostics and distributes computerized audiology and hearing-instrument fitting equipment. The company was founded in 1957 and is headquartered in Ballerup, Denmark.

MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland.

MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland.